Cell cycle synchronizing properties of staurosporine
Tóm tắt
Staurosporine (SSP) is a microbial alkaloid isolated from cultures of Streptomyces. For its ability to specifically inhibit protein kinase C and other serine/threonine and tyrosine protein kinases, SSP has been utilized recently to synchronize cells in G1 and/or G2 phases of the cell cycle. In the present paper we focus on the synchronizing properties of SSP with respect to three human normal cell types (PHA-activated peripheral blood lymphocytes, HS-68 and WI-38) and eight human tumor cell cultures (SV-40 transformed WI-38, SW48, SW480, A253, T-24, A549, MOLT-4 and HL-60). We describe procedures for maintenance and synchronization of these cells in culture. We provide the DNA/RNA flow cytometric methodology to verify cell synchronization and to evaluate the position of cell accumulation in specific phase and the level of synchrony. Synchronization in G1 is being achieved in the three normal cell lines after 24h SSP treatment with low concentrations (5–10 ng/ml) and in G2 after 24h treatment at higher SSP concentrations (50–100 ng/ml) in four of the eight tumor cell lines (A253, SW48, SW480 and A549). The other four tumor cell cultures (SV-40, WI-38, T-24, MOLT-4 and HL-60) show, at 50–100 ng/ml SSP concentration, an apparent G2 block, which is actually due to the presence of cells entering higher DNA ploidy levels. All other cell type/SSP dose combinations fail to induce cell synchronization. We also report a summary of the literature data about cell synchronization with SSP in other cell lines. Our results, together with the results from the literature, suggest that, while SSP may be useful for synchronizing normal cells in G1, its application for synchronizing tumor and/or transformed cells is limited. Critical comments follow, as well as suggestions and words of caution addressed to the future users of SSP as a cell synchronizing agent.
Tài liệu tham khảo
Abe K, Yoshida M, Usui T, Horinouchi S, Beppu T (1991). Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases. Exp Cell Res 192: 122–127.
Akinaga S, Nomura K, Gomi K, Okabe M (1994). Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell cycle distribution of human epidermoid carcinoma, A431 cells. Cancer Chemother Pharmacol 33: 273–280.
ATCC (1992). Catalogue of cell lines and hybridomas, 7th ed.
Bagwell CB (1993). Theoretical aspects of flow cytometry data analysis. In: KD Bauer, RE Duque, TV Shankey (eds), Clinical flow cytometry, Baltimore: Williams & Walkins, pp 41–61.
Baserga R (1990). The cell cycle: myth and realities. Cancer Res 50: 6769–6771.
Beach D (1994). Cyclins, cell cycle control and neoplasia. Adv Oncol 10: 3–9.
Bruno S, Ardelt B, Skierki JS, Traganos F, Darzynkiewicz Z, (1992). Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Cancer Res 51: 470–473.
Crissman HA, Gadbois DM, Tobey RA, Bradbury EM (1991). Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. Proc Natl Acad Sci USA 88: 7580–7584.
Crompton NEA, Hain J, Jaussi R, Burkart W (1993). Staurosporine- and radiation-induced G2-phase cell cycle blocks are equally released by caffeine. Radiation Res 135: 372–379.
Darzynkiewicz Z (1990). Differential staining of DNA and RNA in intact cells and isolated cell nuclei with acridine orange. In: Z Darzynkiewicz, HA Crissman (eds), Methods in cell biology. New York: Academic Press, 33: 285–298.
Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD (1989). Potent selective inhibitors of protein kinase C. FEBS Lett 259: 61–63.
Fujita-Yamaguchi Y, Kathuria S (1988). Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-1 receptor. Biochem Biophys Res Commun 157: 955–962.
Gadbois D, Crissmann HA, Tobey RA, Bradbury ME (1992). Multiple kinase arrest points in the G1 phase of non transformed mammalian cells are absent in transformed cells. Proc Natl Acad Sci USA 89: 8626–8630.
Gong J, Traganos F, Darzynkiewicz Z (1994). Staurosporine blocks cell progression through G1 between the cyclin D and cyclin E restriction points. Cancer Res 54: 3136–3139.
Gong J, Traganos F, Darzynkiewicz Z (1993). Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements. Cancer Res 53: 5096–5099.
Lin Y, Chrest FJ, Gabrielson EW (1992). Reversible G1 arrest of a human lung epithelial cell line by staurosporine. J Cell Physiol 152: 646–653.
Mateos S, Slijepcevic P, MacLeod RAF, Bryant PE (1994). DNA double-strand break rejoining in xrs5 cells is more rapid in the G2 than in the G1 phase of the cell cycle. Mutation Res, DNA Repair 315: 181–187.
Norbury C, Nurse P (1992). Animal cell cycles and their controls. Annu Rev Biochem 61: 441–470.
Rabinovitch PS (1993). Practical considerations for DNA content and cell cycle analysis. In: KD Bauer, RE Duque, TV Shankey (eds), Clinical flow cytometry. Baltimore: Williams & Walkins, pp 117–142.
Tamaoki T, Monoto H, Takahashi I, Kato Y, Morimoto M, Tomita F (1986). Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 135: 397–402.
Traganos F, Gong J, Ardelt B, Darzynkiewicz Z (1984). Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis. J Cell Physiol 158: 535–544.
Tse H, Dulton RW (1976). Separation of helper and suppressor T lymphocytes on a Ficoll velocity sedimentation gradient. J Ex Med 143: 1199–1210.
Yen A, Varvayanis S, Platko JD (1993). 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells. Cancer Res 53: 3085–3091.